Repare Therapeutics(RPTX) - 2024 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 Repare Therapeutics Inc. (Exact Name of Registrant as Specified in its Charter) Québec Not applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) St-Laurent, Québec, Canada H4S 1Z9 (Address of principal executive offices) (Zip Co ...